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Background: As the case detection rates of hypertension increase in adult Nigerians, achieving 
target blood pressure (BP) control has become an important management challenge.
Objectives: To describe medication adherence and BP control amongst adult Nigerians with 
primary hypertension attending a primary care clinic of a tertiary hospital in a resource-poor 
environment in Eastern Nigeria.
Methods:  A  cross-sectional  study  was  carried  out  in  140  adult  patients  with  primary 
hypertension who have been on treatment for at least 6 months at the primary care clinic of 
Federal Medical Centre, Umuahia. A patient was said to have achieved goal BP control if the 
BP was < 140 per 90 mmHg. Adherence was assessed in the previous 30 days using a pretested 
researcher-administered questionnaire on 30 days of self-reported therapy. Adherence was 
graded using an ordinal scoring system of 0–4; an adherent patient was one who scored 
4 points in the previous 30 days. Reasons for non-adherence were documented.   
 
Results: Adherence to medication and BP control rates were 42.9% and 35.0% respectively. BP 
control was significantly associated with medication adherence (p = 0.03), antihypertensive 
medication duration ≥3 years (p = 0.042), and taking ≥ one form of antihypertensive medication 
(p = 0.04). BP at the recruitment visit was significantly higher than at the end of the study 
(p = 0.036). The most common reason for non-adherence was forgetfulness (p = 0.046). 
Conclusion: The rate of BP control amongst the study population was low, which may be 
connected with low medication adherence. This study urges consideration of factors relating 
to adherence alongside other factors driving goal BP control.
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Observance du traitement et contrôle de la pression artérielle chez des adultes souffrant 
d’hypertension primaire soignés dans un centre de soins primaires d’un hôpital tertiaire à 
l’Est du Nigéria
Contexte: Comme les taux de détection de cas d’hypertension augmentent chez les Nigérians 
d’âge adulte, le contrôle de la pression artérielle (Pa) est devenu un important défi à gérer.
Objectifs: Décrire l’observance du traitement et le contrôle de la Pa chez les Nigérians d’âge 
adulte souffrant d’hypertension primaire traités dans un centre de soins primaires d’un hôpital 
tertiaire dans un environnement caractérisé par la rareté des ressources  à l’Est du Nigéria.
Méthodes: Une étude transversale a été réalisée auprès de 140 patients adultes souffrant 
d’hypertension primaire traitées depuis au moins 6 mois au centre de soins primaires du 
Centre médical fédéral d’Umuahia. Il est considéré qu’un patient a atteint son objectif de 
contrôle de  la Pa si celle--ci est < 140 par 90 mmHg. L’observance a été évaluée dans les 
30 jours précédents en utilisant un questionnaire prétesté administré par les chercheurs sur 
30 jours d’autothérapie. L’observance a été notée en utilisant un système de notation ordinal 
allant de 0 à 4 ; un patient suivant à son traitement se voyait accorder une note de  4 dans les 
30 jours précédents. Les raisons d’une mauvaise observance ont été documentées.    
Résultats: Les taux d’observance du traitement et de contrôle de la Pa s’élevaient respectivement 
à 42,9% et 35.0%. Le contrôle de la Pa est fortement associé à l’observance du traitement   
(p = 0.03), la durée du traitement antihypertensif  ≥ 3 ans (p = 0.042), et la prise ≥d’une forme 
de traitement anti hypertensif (p = 0.04). Lors de la visite de recrutement, la Pa était nettement 
plus élevée qu’à la fin de l’étude (p = 0.036). La raison la plus courante de la non observance 
du traitement est l’oubli (p = 0.046). 
Conclusion: Le taux de contrôle de la Pa parmi la population étudiée était faible, ce qui peut 
avoir un rapport avec la faible observance du traitement. Cette étude pousse à prendre en 
considération les facteurs liés à l’observance ainsi qu’aux autres facteurs liés au contrôle de la Pa.Original Research
doi:10.4102/phcfm.v5i1.446 http://www.phcfm.org
Introduction
Hypertension is the most common cardiovascular disorder, 
posing  a  major  clinical  and  public  health  challenge  to 
populations in socio-economic and demographic transition.1 
Studies have demonstrated that blood pressure (BP) tends to 
increase with age, and the relationship between BP and the 
risk of cardiovascular events is continuous, consistent and 
independent of other risk factors.2,3 As the Nigerian population 
ages, the prevalence of hypertension is expected to increase 
unless  effective  preventive  measures  are  implemented. 
Hypertension is therefore one of the most common causes of 
disability and death amongst the adult Nigerian population, 
and plays an important role in the causation of hypertensive 
heart failure, heart attack, arteriosclerosis, renal failure and 
stroke.4 Adequate control of BP was reported to reduce the 
incidence of stroke by an average of 35% – 40%, myocardial 
infarction by 20% – 25% and heart failure by more than 50%.5 
For  individuals  of  40–70  years  of  age  each  increment  of 
20 mmHg in systolic BP or 10 mmHg in diastolic BP doubles 
the risk of cardiovascular disease across the entire BP range 
from 115 per 75 mmHg to 185 per 115 mmHg.6 
Achieved BP is not synonymous with target or goal BP control, 
and the benefits of goal BP control have been elucidated in 
previous  studies.7,8 The  primary  focus  of  antihypertensive 
therapy is to achieve a goal BP of < 140 per 90 mmHg for 
the general population and < 130 per 80 mmHg for special 
high-risk  populations  such  as  patients  with  diabetes 
mellitus,  renal  disease  and  adverse  cardiovascular  events 
such as myocardial infarction and stroke.2,3 The magnitude 
of  BP  control  differs  between  the  developing9,10,11  and 
developed countries.12 In Nigeria, BP control rates in adult 
patients range from 24.2% to 35.8% according to published 
studies.9,10,11,13,14 These disparities are probably due to a milieu 
of  limited  healthcare  facilities,  widespread  personal  and 
family poverty, ignorance, poverty of knowledge and other 
diverse factors.15,16 
Blood  pressure  control  is  influenced  by  multiple 
factors,2,3,13,15,16,17,18 some of which are related to the patients, the 
health professionals and government. Amongst the patient-
related factors is adherence to antihypertensive medication. 
Adherence  is  one  of  the  challenges  of  antihypertensive 
medication  and  is  defined  conceptually  as  the  degree  to 
which the patient conforms with treatment as prescribed.19 
Several  methods  of  measuring  adherence  to  medication 
have  been  described.20,21,22 There  is  no  ‘gold  standard’  for 
precise  measurement  of  adherence.20  Clinical  measures 
include the use of questionnaires for 30 days of self-reported 
(self-administered)  therapy.  Pharmacological  measures 
involve determination of serum and urinary concentrations 
of  drugs  or  using  biological  markers  integrated  into  the 
tablets.21 Although having higher sensitivity and specificity, 
pharmacological methods are not routinely used in clinical 
practice.21 Recently the medication event monitoring system 
(MEMS) was introduced.22 Assessment of adherence using 
the MEMS device involves microprocessor-based monitoring. 
Unfortunately the MEMS device is not readily available in 
the study area.
In order to provide necessary health services for management 
of  hypertension  in  health  facilities  in  Nigeria,  clinicians 
should  identify  and  determine  the  prevailing  level  of  BP 
control and factors responsible for poor BP control. This study 
therefore provides additional evidence on the contribution of 
adherence factors to the growing problem of goal BP control 
in Nigeria. It is against this background that the researchers 
were  motivated  to  study  medication  adherence  and  BP 
control amongst adults with primary hypertension attending 
a primary care clinic of a tertiary medical centre in a resource-
poor environment in Eastern Nigeria.
Ethical considerations
The Ethics Committee of the Federal Medical Centre (FMC), 
Umuahia, Abia State, Eastern Nigeria, granted approval for 
the study. Informed written consent was obtained from the 
respondents before recruitment into the study.  
 
Method
Design          
This  was  a  clinic-based  descriptive  cross-sectional  study 
carried out on 140 patients from April 2011 to November 2011 
at the Department of Family Medicine of the FMC, Umuahia, 
which is a tertiary hospital in Abia State, Eastern Nigeria.
Setting
Umuahia is the capital of Abia State in south-east Nigeria. 
The State is endowed with abundant mineral and agricultural 
resources, with a supply of professional, skilled, semi-skilled 
and unskilled manpower. Economic and social activities here 
are low compared to industrial and commercial cities such as 
Onitsha, Port Harcourt and Lagos. Until recently the capital 
city of Lagos and its environs have witnessed an upsurge 
in the number of banks, hotels, schools, markets, industries 
and fast food restaurants in addition to changing dietary and 
social lifestyles.  
 
The FMC is located in the metropolitan city of Umuahia. This 
is a tertiary hospital established with the tripartite mandate 
of  service  delivery,  training  and  research,  and  serves  as 
a  referral  centre  for  primary  and  secondary  public  health 
institutions as well as missionary and private hospitals in 
Abia and the neighbouring states of Imo, Ebonyi, Rivers and 
Akwa Ibom. The Department of Family Medicine serves as 
a primary care clinic within the tertiary hospital setting of 
the medical centre. All adult patients, excluding those who 
need emergency healthcare services, paediatric patients and 
antenatal women, are first seen at the Department of Family 
Medicine,  where  diagnoses  are  made.  Patients  who  need 
primary  care  are  managed  and  followed  up  in  the  clinic, 
whilst  those  who  need  specialist  care  are  referred  to  the 
respective core specialist clinics for further management. The 
clinic is run by consultant family physicians and postgraduate 
resident doctors in Family Medicine.
Inclusion and exclusion criteria
The inclusion criteria were adult hypertensive patients aged 
≥ 18 years who gave informed verbal consent, had been on 
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outpatient  treatment  for  hypertension  in  the  clinic  for  at 
least 6 months, and who recorded at least three clinic visits 
(recruitment visit, penultimate visit before the end of study, 
and end of study visit). Exclusion criteria included critically 
ill patients, those with an established cause of hypertension, 
patients whose recommended2,3 goal BP is < 130 per 80 mmHg, 
and  special  high-risk  populations  such  as  hypertensive 
patients with diabetes mellitus, renal disease and previous 
adverse cardiovascular events such as myocardial infarction 
and stroke. The eligible patients were consecutively recruited 
for the study. 
Sampling
Sample size estimation was determined using the formula23 
for estimating minimum sample size for descriptive studies 
when  studying  proportions  with  an  entire  population 
size  <  10  000  using  an  estimated  population  size  of  200 
adult hypertensive patients, based on the previous annual 
hypertensive  patients’  attendance  records  at  the  clinic. 
These 200 adult hypertensives excluded other hypertensive 
patients referred to and being followed up in other medical 
outpatients’  clinics  in  the  medical  centre.  The  diabetic 
hypertensives were also excluded from this recorded number. 
The authors assumed that 50% of the adult hypertensives 
would have a good BP control rate and adhere to treatment, 
at a 95% confidence level with a 5% margin of error. This gave 
a sample estimate of 132 patients. A sample size of 140 adult 
hypertensive patients was selected to allow for attrition.
Data collection methods
Adherence was assessed by use of a pretested, interviewer-
administered questionnaire on 30 days of self-administered 
and reported therapy. Patients were seen at the recruitment 
visit,  penultimate  visit  before  the  end  of  the  study  and 
then  at  the  end  of  the  study  visit.  At  the  end  of  study 
visit the adherence section of the data collection tool was 
administered. Information collected at the end of study visit 
included,  (1)  how  many  times  per  day  do  you  take  your 
BP medication?, (2) how many tablets do you take specific 
to your hypertensive condition?, (3) how often do you take 
your BP medication (all times, most times, sometimes, rarely, 
never),  (4)  how  many  dose(s)  of  your  antihypertensive 
drugs have you missed in the previous one month? and (5) 
how  much  of  your  previous  BP  medication  is  remaining 
after the previous one-month visit? Adherence was graded 
using  an  ordinal  scoring  system  of  0–4  points  developed 
by  the  authors  from  a  review  of  the  literature9,10,11,12,13,14 
as follows: all the time = 4 points, most times = 3 points, 
sometimes = 2 points, rarely = 1 point, never = 0. Four points 
indicated adherence, whilst 0–3 points meant non-adherence. 
Reasons for non-adherence were documented for those who 
scored 0–3 points. 
Pretesting  of  the  adherence  section  of  the  data  collection 
tool  was  done  internally  at  the  Family  Medicine  clinic  of 
the FMC and externally at the Family Medicine clinic of the 
FMC in Owerri, Eastern Nigeria. Five diabetic hypertensive 
patients of the FMC in Umuahia were randomly used for 
pre-testing of the questionnaire, which lasted for one day, 
and  five  hypertensive  patients  were  used  in  the  FMC  in 
Owerri. The pretesting was done to assess the applicability 
of the questionnaire tool internally and externally. All of the 
patients used for pretesting of the questionnaire instrument 
gave  valid  and  reliable  responses,  confirming  the  clarity 
and  applicability  of  the  questionnaire  tool,  and  questions 
were interpreted with the same meaning as intended. The 
questionnaire  was  administered  by  three  resident  doctors 
who were recruited and trained for the study, once to each 
eligible respondent at the end of study visit.
BP readings were based on the seventh report of the Joint 
National Committee on Prevention, Detection, Evaluation, 
and  Treatment  of  High  Blood  Pressure  classification  and 
guidelines.2  The  baseline  BP  was  recorded  at  the  time  of 
recruitment (recruitment visit), subsequent BP was measured 
at the penultimate visit before the end of study visit, and then 
at the end of study visit. The duration of hypertension, class 
and number of antihypertensive drugs and reasons for non-
adherence to antihypertensive medication were documented. 
Fasting  blood  sugar,  urinalysis,  urea  and  creatinine  were 
done. Diagnosis of diabetes mellitus was based on a venous 
plasma glucose level of ≥ 126 mg/dL after an overnight fast, 
which was confirmed by a repeat test at the second clinic 
visit.24 The basic demographic variables of age, sex, marital 
status, education and occupation were also documented.
Operational definitions
The  authors  defined  hypertension  as  a  systolic  and/or 
diastolic  BP  ≥  140  per  90  mmHg  or  documented  use  of 
antihypertensive  medications  in  a  person  previously 
diagnosed  with  hypertension.2  A  patient  was  defined  as 
having goal BP control if his or her BP at the end of study visit 
was < 140 per 90 mmHg.2,3 An adherent patient was defined 
as one who had a score of 4 points (took the prescribed doses 
of antihypertensive all the time) for the previous 30 days by 
the end of the study visit.
Data analysis 
The  results  generated  were  analysed  using  Statistical 
Package  for  Social  Sciences  (SPSS)  software  version  13.0 
(Microsoft,  Chicago,  IL,  United  States  of  America  [USA]) 
for calculation of percentages for categorical variables and 
means for continuous data. Means with standard deviations 
of continuous variables were generated where appropriate. 
Percentages and frequencies were compared by Chi-square 
analysis and the Student’s t-test served to compare means. 
The level of statistical significance was set at p < 0.05.
Results 
The age of the hypertensive patients ranged from 32 to 83, 
years with mean age of 52 ± 7.4 years. There were 56 (40.0%) 
males and 84 (60.0%) females, with a male to female ratio of 
1: 1.5 (Table 1).Original Research
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Ninety-eight (70.0%) patients had been hypertensive for less 
than 3 years, whilst 42 (30.0%) had been hypertensive for 3 
years or more. Of the 49 patients that had good BP control, 
29 (59.2%) had been hypertensive for 3 years or more whilst 
20  (40.8%)  had  been  hypertensive  for  less  than  3  years. 
The  difference  between  the  two  groups  was  statistically 
significant (χ2 = 3.18; df = 1; p - value = 0.042) (Table 2).
The mean BP at the recruitment visit (170.6 ± 10.4 per100.8 
mmHg  ±  12.3  mmHg)  was  higher  than  the  mean  BP  at 
the  end  of  study  visit  (130.6  ±  4.4  per  80.3  mmHg  ±  8.6 
mmHg). This difference was statistically significant (t = 4.26; 
p-value = 0.036). 
Sixty (42.9%) out of 140 patients were adherent, whilst 80 
(57.1%) were not adherent. Of the 49 patients who had good 
BP control, 45 (91.8%) were adherent whilst 4 (8.2%) were not 
adherent. BP control was significantly higher in those that 
adhered to antihypertensive medication compared with non-
adhering patients (χ2 = 5.12; df = 1; p-value = 0.03) (Table 3).
Blood  pressure  control  by  number  of  antihypertensive 
medications  (Table  4).  The  difference  between  taking  one 
antihypertensive  medication  and  taking  more  than  one 
antihypertensive  medication  was  statistically  significant 
(χ2 = 5.11; df = 2; p-value = 0.04) (Table 4).
The  most  common  reason  proffered  for  non-adherence  to 
medications by the hypertensive patients was forgetfulness 
(32.4%).  Other  reasons  included  feeling  of  well-being 
(25.6%),  lack  of  funds  (25.6%),  advice  by  spiritual  leaders 
(8.7%) and herbal remedies (7.7%). This marginal difference 
was statistically significant (χ2 = 6.03; df = 4; p-value = 0.046) 
(Table 5).
Discussion
The BP control rate in this study of 35.0% is higher than the 
24.2% reported in Port Harcourt, Rivers State, south-south 
Nigeria,10 31.4% reported in Osogbo, south-west Nigeria,11 
and 33% reported in Kano, Northern Nigeria.14 However, the 
BP control rate in this study is lower than the 35.8% reported 
in Ilorin, North Central Nigeria13 and 40.0% reported in South 
Africa.25  The  findings  of  this  study  corroborate  previous 
reports that adequate BP control rates are low in Nigeria and 
occur  only  in  a  fraction  of  treated  hypertensives.9,10,11,12,23,14 
These  disparities  are  probably  due  to  a  milieu  of  limited 
healthcare facilities, misconceptions and health beliefs about 
hypertensive disorder.26 
Although adequate BP control does not completely obviate 
the  risk  of  developing  complications  of  hypertension, 
experience from developed countries has left no doubt that 
there is no magic bullet for adequate BP control amongst 
hypertensives.2,3 Although low BP control rates are due to 
multiple factors, in this study this may not be unconnected 
from  patient  factors  of  adherence  (forgetfulness)  to 
medication  amongst  others.  Clinicians  attending  to  adult 
Nigerians with primary hypertension should therefore ask 
specific questions in order to uncover medication problems. 
TABLE 1: Basic demographic variables in the study population.
Age (years) n %
18–39                                                                                                                                     10 17.2
40–60                                                                                                                                   86 61.4
> 60                                                                                                                                       44 31.4
Total    140  100.0
Sex
Male      56   40.0
Female        84 60.0
Total      140  100.0
Marital status
Single      4 2.9
Married                                                                                                                              101 72.1
Separated or divorced                                                                                                                 7 5.0                                                                                                                                                                                                                                         
Widowed     28 20.0
Total    140 100.0
Education
No formal education                                                                                                                9 6.4
Primary 36 25.8
Post-primary                                                                                                                          95 67.8
Total   140 100.0   
Occupation
Trading      43 30.7
Public servant                                                                                                                      31 22.1
Farming 22 15.7
Artisan                                                                                                                                    11 7.9
Driver                                                                                                                                        6 4.3
Clergy                                                                                                                                         4 2.9
Retired                                                                                                                                    23 16.4            
Total   140 100.0
n, Given as number of patients.
TABLE 2: Relationship between duration of antihypertensive medication and 
blood pressure control. 
Duration of medication  Controlled Not controlled
n % n %
< 3 years                                                           20 40.8         78 85.8
≥ 3 years                                                           29 59.2           13 14.2
Total   49 100.0         91 100.0
n, Given as number patients.
χ2 = 3.18; df = 1; p-value = 0.042
TABLE 3: Association between adherence to medication and blood pressure control. 
Medication pattern                                  Controlled Not controlled
n % n %
Adherence  45 91.8         15 16.5
Non-adherence                                             4 8.2          76 83.5
Total   49 100.0        91 100.0
n, Given as number patients.
χ2 = 5.12; df = 1; p-value = 0.03
TABLE 4: Blood pressure control by number of antihypertensive medications.
Number of drugs                            Controlled Not controlled  
n % n %
One drug                                             9 18.4            52 57.1
Two drugs                                          17 34.7             24 26.4
T ≥Three drugs                                     23 46.9          15 16.5
Total                                                  49 100.0          91 100.0 
n, Given as number patients.
χ2 = 5.11; df = 2; p-value = 0.04.
in the early stages, since hypertension is a silent killer that 
usually shows no specific symptoms. This will enable adult 
Nigerians with primary hypertension to benefit from the life-
saving benefits of antihypertensive medications.   Original Research
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This  study  has  shown  that  BP  control  was  significantly 
higher amongst patients that adhered to their medication. 
The adherence rate of 42.9% in this study is lower than that 
of 45.0% reported in Kano, Northern Nigeria14 and of 43.0% 
reported in Lake City in the USA.27 The findings of this study 
have  demonstrated  the  contribution  of  adherence  in  BP 
control amongst the study population. Although there may be 
other inter-patient variability amongst the study population 
that may contribute to poor BP control despite adherence to 
medications, efforts should therefore be made by clinicians 
to ensure that their adult hypertensive patients adhere to 
their  antihypertensive  medications.  Clinicians  inquiring 
about  medication  adherence  during  their  encounters  with 
adult hypertensive patients remains imperative in the drive 
to  lower  BP  to  goal  levels.  Without  regular  feedback  on 
medication adherence between clinicians and hypertensive 
patients, a patient with poor BP control may never achieve 
their BP target.
 
Blood  pressure  control  was  significantly  associated 
with  duration  of  hypertension.  The  finding  of  a  higher 
BP  control  rate  amongst  patients  who  had  had  their 
hypertensive  condition  for  three  or  more  years  could  be 
attributed to their increasing contact with the hospital and 
other  health  facilities  where  the  importance  of  consistent 
antihypertensive medication is emphasised. These patients 
with longer duration of hypertensive medication, by virtue 
of their frequent contact with health facilities, are also more 
likely to be aware of the fatal and non-fatal complications 
of uncontrolled BP. In addition, it could be a reflection of 
wider  social  interaction  with  other  hypertensive  patients 
who are adherent to antihypertensive medication. This result 
supports the observation by Nichol Venturin and Sung28 on 
critical  evaluation  of  literature  on  medication  compliance 
that adherence to medication tends to increase over time for 
patients on chronic medication such as hypertensive patients.             
This study has also shown that BP control is related to the 
number  of  antihypertensive  medications.  This  finding 
is  similar  to  reports  from  other  parts  of  Nigeria,14,29 and 
is  consistent  with  a  rational  approach  for  treatment  of 
hypertension in adult Black hypertensives.2 This could be a 
reflection  of  the  pathophysiological  mechanisms  involved 
in  Black  hypertensive  patients,2  and  provides  additional 
evidence  on  the  growing  need  for  combination  therapy 
amongst the study population. This therefore calls for wider 
application  of  evidence-based  hypertensive  management 
guidelines in addition to diverse actions against hypertension, 
because adequate control of BP is associated with more health 
benefits and less risk of adverse cardiovascular events.4,15
Although low BP control rates are polyfactorials, this study 
observed  that  the  most  common  reason  proffered  for  by 
non-adhering hypertensive patients was forgetfulness. This 
could be attributed to life-competing psychosocial demands 
amongst the study population, who were mainly traders. This 
finding has buttressed the report that psychosocial variables 
are  additional  barriers  to  adherence  to  antihypertensive 
medication.30 Non-adherence  resulting  from  forgetfulness, 
amongst other reasons, could lead to poor BP control and 
higher costs in physicians’ visits. This has also shown that 
forgetting  to  take  antihypertensive  medication  is  not  a 
problem  that  adult  patients  outgrow.  Awareness  of  this 
by  clinicians  is  crucial  for  optimal  care  of  adult  Nigerian 
hypertensive patients in the study area. Clinicians should 
therefore  be  aware  of  these  subtleties,  because  they  can 
influence the quality and quantity of care delivered to these 
patients.   
Implications of the study
Despite the publication of major clinical trials on the benefits 
of  attaining  target  BP  amongst  hypertensives,  the  actual 
BP control rates in adult hypertensive Nigerians remains a 
management challenge. Suffice it to say that substantial risk 
of  cardiovascular  events  still  exists,  despite  treatment  of 
hypertension, depending on the difference between achieved 
BP and target BP. However, the bulk of mortality associated 
with  cardiovascular  disease  is  principally  attributed  to 
unsatisfactory BP control resulting in target organ damage. 
Hence  there  is  a  need  to  determine  the  magnitude  of  BP 
control amongst adult hypertensives in the study centre as 
part of the search for an effective intervention to prevent 
complications of hypertension amongst the study population. 
This  study  therefore  provides  additional  evidence  on  the 
growing problem of BP control rates in Nigeria, and calls for 
improved management of hypertension through adherence 
counselling as well as strengthening the quality of care. This 
will enable adult hypertensive Nigerians to benefit from the 
life-saving advantages of goal BP control. 
Limitations of the study
The limitations imposed by the self-reported and qualitative 
measure of adherence for the study are recognised by the 
authors. Also, the sample size for the study was relatively 
small, but was more than the minimum estimated sample 
size for the study and was the number of patients seen within 
the proposed duration of the study.  
The  questionnaire  was  administered  by  three  resident 
postgraduate medical doctors. This could have introduced 
interviewers’  influence  and  bias,  since  some  patients 
couldn’t clinically give true responses to questions related 
to adherence in the presence of their physicians. However, 
pre-testing  of  the  questionnaire  internally  and  externally 
using the same resident medical doctors did not reveal this 
TABLE 5: Reasons for non-adherence to medication (N = 80).
Reason for non-adherence to medication     Yes                       No
n %      n %      
Forgetfulness  71 32.4        9 5.0
Feeling of well-being and cure                              56 25.6      24 13.3
Lack of funds (to purchase drugs)                             56 25.6     24 13.3
Advice by spiritual leaders                                   19 8.7         61 33.6
Herbal remedies                                                      17 7.7         63 34.8
Total responses                                                      219 100.0   181 100.0
Note: Multiple responses were recorded for some patients; percentages represent proportion 
of responses obtained. 
n, Given as number patients.
χ2 = 6.03; df = 4, p-value = 0.046.Original Research
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limitation.  In  addition,  the  respondents  were  assured  of 
confidentiality prior to the interview. 
Conclusion
The BP control rate amongst the study population was low. 
This may not be unconnected with low adherence amidst 
other  factors  determining  target  BP  control.  The  most 
common reason for non-adherence was forgetfulness. This 
study urges consideration of adherence factors alongside the 
milieu of other factors driving goal BP control. The use of 
reminders such as an alarm system or beepers amongst other 
interventions to overcome forgetfulness is advocated.
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